SOX2 and breast cancer: Considering that PGR (the PR-encoding gene) is a direct ER target gene (39), and FOXA1 is a critical pioneer factor for ER (40), it can be hypothesized that Sox2 altered ER transcriptional activity in FMCs of the present study as it does in breast cancers (41).